Neurobiological mechanisms of transcranial magnetic stimulation and its comparative efficacy in tension headache and migraine

Cover Page

Cite item

Abstract

Transcranial magnetic stimulation (TMS) is one of the nonpharmacological methods to affect the central nervous system. This approach allows a noninvasive stimulation of the cerebral cortex. The method is based on the ability of magnetic fields to penetrate the bone and muscle structures. The induced magnetic field depolarizes the neuronal membrane, and the generated action potential propagates through the conducting pathways. In the review, the biophysical effects of TMS, as well as its neural, immune, mediator and macro effects are analyzed. The main contraindications to TMS and its side effects are considered. Nonpharmacological treatment of tension headache (TH) and migraine is a promising direction, since the incidence of these types of primary headaches reaches 40-65 and 11-22%, respectively. In the article the current state of study of various modes and durations of TMS procedure, and the site of exposure in TH and migraine are considered. In recent years there is noted an increase in the number of evidence-based randomized, placebo-controlled studies on the effectiveness of TMS in migraine therapy. Much attention is given to evaluation of the effect of TMS in migraine. There is much evidence of the positive effect of this procedure. However, the amount of examined volunteers does not provide the highest level of evidence. Experiments on animals and use of functional neurovisualization techniques contribute to understanding of the mechanisms of TMS effect. Active participation of physiologists, neurophysiologists and biophysicists in these research works will permit evaluation of the effectiveness of TMS in nonpharmacological treatment of patients with pain syndrome. This approach will improve the working capacity and quality of life in TH and migraine.

About the authors

Natalia D. Sorokina

A.I. Evdokimov Moscow State University of Medicine and Dentistry

Author for correspondence.
Email: sonata5577@mail.ru
ORCID iD: 0000-0002-5709-1041
SPIN-code: 6820-6477
ResearcherId: Q-8937-2018

PhD in Biological sciences, Professor of the Department of Normal Physiology and Medical Physics of the Medical Faculty

Russian Federation, 20/1, Delegatskaya street, Moscow, 127473

Sergey S. Pertsov

A.I. Evdokimov Moscow State University of Medicine and Dentistry; P.K. Anokhin Research Institute of Normal Physiology

Email: s.pertsov@mail.ru
ORCID iD: 0000-0001-5530-4990
SPIN-code: 3876-0513
ResearcherId: A-6697-2017

Head of the Department of Normal Physiology and Medical Physics of the Medical Faculty; MD, PhD, Corresponding Member of Russian Academy of Sciences, Professor, Deputy Director for Research, Head of the Laboratory of Systemic Mechanisms of Emotional Stress

Russian Federation, 20/1, Delegatskaya street, Moscow, 127473; P.O.B. 72, 125315 Moscow

Gennady V. Selitsky

A.I. Evdokimov Moscow State University of Medicine and Dentistry

Email: gvselitsky@mail.ru
ORCID iD: 0000-0003-0642-4739
SPIN-code: 2173-9401
ResearcherId: Q-8986-2018

MD, PhD, Professor of the Department of Nervous Diseases of the Medical Faculty

Russian Federation, 20/1, Delegatskaya street, Moscow, 127473

References

  1. Eldaief M, Pascual-Leone A. Transcranial magnetic stimulation in neurology. Clinical practice. 2013; 12:519-25.
  2. Deblieck C, Thompson B, Iacoboni M, et al. Correlation between motor and phosphene thresholds: a transcranial magnetic stimulation study. Hum Brain Mapp. 2008;6:662-70.
  3. Dodick DW, Schembri CT, Helmuth M, et al. Transcranial magnetic stimulation for migraine: a safety review. Head-ache. 2010;50(7):1153-63. doi:10. 1111/j.1526-4610.2010.01697.x
  4. Sorochinskiy AA. Transkranial'naya magnitnaya stimulyatsiya. Izvestiya Yuzhnogo Federal'nogo Universiteta. 2010;110(9):207-10. (In Russ).
  5. Sorokina ND, Selitskiy GV, Smirnov VM. Izmenenie bioelektricheskoy aktivnosti mozga pod vliyaniem oposredo-vannogo kratkovremennogo peremennogo magnitnogo polya u zdorovykh i bol'nykh epilepsiey. Rossiyskiy Med-itsinskiy Zhur-nal. 2012;6:11-4. (In Russ).
  6. Voytenkov VB, Mally J, Skripchenko NV, et al. Transkranial'naya magnitnaya stimulyatsiya kak diagnosticheskaya i terapevticheskaya metodika. Nevrologicheskiy Zhurnal. 2015;20(5):4-13. (In Russ).
  7. Chervyakov AV, Piradov MA, Savitskaya NG, et al. Novyy shag k personifitsirovannoy meditsine. Navigatsionnaya sistema transkranial'noy magnit-noy stimulyatsii (NBS eXimia Nexstim). Annaly Nevrologii. 2012;6(3):37-46. (In Russ).
  8. Chervyakov AV, Piradov MA, Nazarova MA, et al. Kartirovanie motornogo predstavitel'stva m. abductor pollicis brevis u zdorovykh dobrovol'tsev s primeneniem navigatsionnoy transkranial'noy magnitnoy stimulyatsii NBS eX-imia NEXSTIM. Annaly Klinicheskoyi Eksperimental'noy Nevrolo-gii. 2012; 6(3):14-6. (In Russ).
  9. Rossi S, Hallett M, Rossini P, et al. Safety of TMS Consensus Group. Clinical safety, ethical considerations, and ap-plication guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009;120 (12): 2008-39. doi: 10.1016/j.clinph.2009.08.016
  10. Bingi VN, Savin AV. Fizicheskie problem deyst-viya slabykh magnitnykh poley na biologicheskie sistemy. Uspekhi Fizicheskikh Nauk. 2003;173(3): 265-300. (In Russ).
  11. Sorokina ND, Selitskii GV, Karpov VA. Indirect short-term influences of alternating magnetic fields on the brain in epilepsy. Neuroscience and behavioral physiology. 2000;30(1):5-8.
  12. Bortoletto M, Veniero D, Thut G, et al. The contribution of TMS-EEG coregistration in the exploration of the human cortical connectome. Neurosci Biobehav Rev. 2015;49:114-24. doi:10. 1016/j.neubiorev.2014.12.014
  13. Huerat P, Volpe T. Synaptic plasticity and oscillations. J Neuro Engin Rehab. 2009;6:7-11.
  14. Keck ME, Welt T., Müller MB, et al. Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system. Neuropharmacology. 2002;43 (1):101-9.
  15. Pradhan S, Kirton A., MacQueen G, et al. The effect of repetitive transcranial magnetic stimulation on dorsolateral prefrontal glutamate in youth with treatment-resistant depression. BMC Proceedings. 2015;9(1):A9. doi: 10.1186/1753-6561-9-S1-A9
  16. Evers S, Hengst K, Pecuch PW. The impact of repetitive transcranial magnetic stimulation on pituitary hormone lev-els and cortisol in healthy subjects. J Affect Disord. 2001;66:83-8.
  17. Valero-Cabre A, Payne BR, Rushmore J., et al. Impact of repetitive transcranial magnetic stimu-lation of the parietal cortex on metabolic brain activity: a 14C-2DG tracing study in the cat. Exp Brain Res. 2005;163:1-12.
  18. Andreou AP, Sprenger T., Goadsby PJ. Cortical modulation of thalamic function during cortical spreading depres-sion- unraveling a new central mechanism involved in migraine aura. J Headache Pain. 2013;14(1):I6. doi: 10.1186/1129-2377-14-S1-I6
  19. Chervyakov AV, Poydasheva AG, Korzhova YuE, et al. Sovremennye terapevticheskie vozmozhnosti ritmicheskoy transkranial'noy magnitnoy stimulyatsii v lechenii zabolevaniy nervnoy sistemy. Russkiy Meditsinskiy Zhurnal. 2014;22:1567-72. (In Russ).
  20. Chervyakov AV, Poydasheva AG, Korzhova YuE, et al. Ritmicheskaya transkranial'naya magnitnaya sti-mulyatsiya v nevrologii i psikhiatrii. Zhurnal Nevro-logii i Psikhiatrii imeni SS Korsakova. 2015; 12:7-18. (In Russ). doi: 10.17116/jnevro20151151127-18
  21. Misra UK, Kalita J, Tripathi GM, et al. Role of β endorphin in pain relief following high rate repetitive transcranial magnetic stimulation in migraine. Brain Stimul. 2017;10(3):618-23. doi: 10.1016/j.brs.2017.02.006
  22. Lipton RB, Dodick DW, Silberstein SD, et al. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial. Lancet Neurolology. 2010;9(4): 373-80. doi: 10.1016/S1474-4422(10)70054-5
  23. Almaraz AC, Dilli E, Dodick DW. The effect of prophylactic medications on TMS for migraine aura. Headache. 2010;50(10):1630-3. doi:10.1111/ j.1526-4610.2010.01787.x
  24. Bhola R, Kinsella E, Giffin N, et al. Single-pulse transcranial magnetic stimulation (sTMS) for the acute treatment of migraine: evaluation of outcome data for the UK post market pilot program. The Journal of Headache and Pain.2015;16:51. doi: 10.1186/s10194-015-0535-3
  25. Brüggenjürgen B, Bake T, Bhogal R, et al. Cost impact of a noninvasive, portable device for patient self administra-tion of chronic migraine in a UK National Health Service setting. Springer Plus. 2016;5:1249-56. doi: 10.1186/s40064-016-2924-8
  26. Lan LH, Zhang XN, Li XP, et al. The efficacy of transcranial magnetic stimulation on migraine: a meta-analysis of randomized controlled trails. Journal of Head acheand Pain. 2017;18:86. doi: 10.1186/s10194-017-0792-4
  27. Naeije G, Y, Ligot N, et al. Occipital transcranial magnetic stimulation discriminates transient neurological symptoms of vascular origin from migraine aura without headache. Europhysiologie Clinique-Clinical Neurophysiology. 2017;47(4): 269-74. doi: 10.1016/j.neucli.2017.05.093
  28. Kalita J, Bhoi SK, Misra UK. Effect of high rate rTMS on somatosensory evoked potential in migraine. Cephalalgia. 2016;37(13):1222-30. doi: 10.1177/0333102416675619
  29. Andreou AP, Holland PR, Akerman S, et al. Transcranial magnetic stimulation and potential cortical and trigemi-nothalamic mechanisms in migraine. Brain. 2016;139(7):2002-14. doi:10.10 93/brain/aww118
  30. Rapinesi C, Del Casale A, Scatena P, et al. Add-on deep Transcranial Magnetic Stimulation (dTMS) for the treatment of chronic migraine: A preli-minary study. Neuroscience Letters. 2016;623(3): 7-12. doi: 10.1016/j.neulet.2016.04.058
  31. Misra UK, Kalita J, Bhoi SK. High frequency repetitive transcranial magnetic stimulation (rTMS) is effective in mi-graine prophylaxis: an open labeled study. Neurological Research. 2012;34(6): 547-55. doi: 10.1179/1743132812Y.0000000045
  32. Kalita J, Laskar S, Bhoi SK, et al. Efficacy of single versus three sessions of high rate repetitive transcranial magnetic stimulation in chronic migraine and tension-type headache. Journal of Neurology. 2016;263(11):2238-46. doi:10.1007/ s00415-016-8257-2
  33. Belyaev AA, Isaykova EI, Son AS. Lechenie migreni metodom transkranial'noy magnitnoy stimulyatsii. Mezhdu-narodnyy Nevrologicheskiy Zhurnal. 2015;73(3):85-9. (In Russ).
  34. Puledda F, Goadsby PJ. The Role of noninvasive neuromodulation in migraine management. European Neurological Review. 2016;11(2):106-108. doi: 10.17925/ENR.2016.11.02.106
  35. Azimova YuE, Rachin AP, Ishchenko KA, et al. Innovatsionnye metody lecheniya migreni. Russkiy Meditsinskiy Zhurnal. 2015;23(3):27-30. (In Russ).
  36. Conforto AB, Amaro E, Goncalves AL, et al. Randomized, proof-of-principle clinical trial of active transcranial magnetic stimulation in chronic migraine. Cephalalgia. 2014;34(6):464-2. doi:10. 1177/0333102413515340
  37. Martelletti P, Jensen RH, Antal A, et al. Neuromodulation of chronic headaches: position statement from the Euro-pean Headache Federation. J Headache Pain. 2013;14(1):86-92.
  38. Iskra DA, Frunza DN. Povtornaya transkranial'-naya magnitnaya stimulyatsiya v lechenii khroni-cheskikh golov-nykh boley napryazheniya. Vestnik Rossiyskoy Voenno-Meditsinskoy Akademii. 2012; 39(9):34-8. (In Russ).
  39. Shirshova EV, Akarachkova ES. Primenenie mag-nitnoy transkranial'noy stimulyatsii pri khroniche-skoy golovnoy boli napryazheniya. Zhurnal Nevrologii i Psikhiatrii imeni SS Korsakova. 2012;7(1):62-4. (In Russ).
  40. Paillere ML, Galinowski A, Rinquenet D et al. Influence of prefrontal target region on the efficacy of repetitive tran-scranial magnetic stimulation in patients with medication-resistant depression: a [(18)F]-fluorodeoxyglucose PET and MRI study. International journal of Neuropsycopharmacology. 2010;13(1):45-59. doi: 10.1017/S146114570900008X

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Sorokina N.D., Pertsov S.S., Selitsky G.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies